ArticleCell reports. Medicine2023

An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2.

Aliyah B Silver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.